With only one week remaining until Europe’s largest event focused on laboratory automation and drug screening, preparations for SLAS Europe 2025 are well under way. Organised by the Society for Laboratory Automation and Screening (SLAS), the conference will be held in Hamburg from 20–22 May. As part of a dedicated series, European Biotechnology Magazine is highlighting twelve of the most innovative SMEs currently operating in the sector. Among them is Switzerland’s ORYL Photonics SA.

British cell and gene therapy CDMO eXmoor Pharma plc, and KU Leuven which has just launched a translational cell and gene therapy hub in Belgium have inked a strategic collaboration supporting the hub’s work in four areas.

Scientists at German Helmholtz Centre Munich have presented a new transport system for gene and cell therapy that overcomes the limitations of viral vectors. An in vivo gene therapy for hereditary blindness corrected the defect in the Rpe65 gene ten times more efficiently than was possible with viral vectors.

The Society of Laboratory Automation and Screening (SLAS) has named the five finalists for the SLAS Europe Poster Award, New Product Award and the SLAS Ignite Award that will be honored in Hamburg on 21 and 22 May, 2025.

Only three weeks to go until Europe’s largest event for laboratory automation and drug screening. SLAS Europe 2025, organised by the Society for Laboratory Automation and Screening (SLAS), will take place in Hamburg from 20-22 May. In a series, European Biotechnology Magazine presents the 12 most innovative SMEs today: Phabioc GmbH.

The pharmaceutical service provider publishes its 2024 Sustainability Report.

Building on the January 2025 ALS drug discovery collaboration with Alchemab Therapeutics, Eli Lilly & Company has secured rights to the first IND-ready program under a US$415m licensing agreement.

Only three weeks to go until Europe’s largest event for laboratory automation and drug screening. SLAS Europe 2025, organised by the Society for Laboratory Automation and Screening (SLAS), will take place in Hamburg from 20-22 May. In a series, European Biotechnology Magazine presents the 12 most innovative SMEs today: German HIPS spin-out Myxotech GmbH.

Astraveus SAS has inked a strategic partnership with NecstGen to evaluate Lakhesys Benchtop Cell Factory for CAR-T therapy manufacturing. Meanwhile, German researchers present a solution to the design of hypoimmunogenic CAR-T cells.

Jena-based organ-on-chip specialist Dynamic42 has inked a strategic partnership with Ohio Lumex Co., Inc. The Ohio-based company, which is an established provider of life science and analytics solutions, will exclusively distribute Dynamic42’s human 3D-sphaeroid-based organ-on-chip models in the U.S. and Canadian markets.